Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype
about
Genotypes coding for low serum levels of mannose-binding lectin are underrepresented among individuals suffering from noninfectious systemic inflammatory response syndromePaths reunited: Initiation of the classical and lectin pathways of complement activationEmerging and Novel Functions of Complement Protein C1qApoptotic cell clearance: basic biology and therapeutic potential.Mannose-binding lectin and the balance between immune protection and complicationNatural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune diseaseNucleic acids and endosomal pattern recognition: how to tell friend from foe?How apoptotic cells aid in the removal of their own cold dead bodiesProtective natural autoantibodies to apoptotic cells: evidence of convergent selection of recurrent innate-like clonesContribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and AutoimmunityA new triggering receptor expressed on myeloid cells (Trem) family member, Trem-like 4, binds to dead cells and is a DNAX activation protein 12-linked marker for subsets of mouse macrophages and dendritic cellsThe endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeabilityMannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease.C1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement FunctionsC1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells.The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization.Integrin α PAT-2/CDC-42 signaling is required for muscle-mediated clearance of apoptotic cells in Caenorhabditis elegansThe alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice.Tyro3 receptor tyrosine kinases in the heterogeneity of apoptotic cell uptake.NETs: the missing link between cell death and systemic autoimmune diseases?Mannose-binding lectin in innate immunity: past, present and future.Mannose-binding lectin 2 gene and risk of adult gliomaDeficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa.The lectin pathway of complement and rheumatic heart disease.Mannose-binding lectin and innate immunity.Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease.Pathogen recognition by the long pentraxin PTX3.B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion.Urokinase and its receptors in chronic kidney disease.Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice.Mannan-binding lectin and complement C4A in Icelandic multicase families with systemic lupus erythematosusComplement component C1q regulates macrophage expression of Mer tyrosine kinase to promote clearance of apoptotic cells.Immunological consequences of apoptotic cell phagocytosisImmunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus.The role of the mannose-binding lectin in innate immunity.Apoptotic cells, at all stages of the death process, trigger characteristic signaling events that are divergent from and dominant over those triggered by necrotic cells: Implications for the delayed clearance model of autoimmunity.MAPK phosphatase-1 is required for regulatory natural autoantibody-mediated inhibition of TLR responses.Complement deficiencies in humans and animals: links to autoimmunity.Lectins offer new perspectives in the development of macrophage-targeted therapies for COPD/emphysema.Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity.
P2860
Q24629244-DAB33278-AC90-468E-BB40-3BFEC2A217ECQ24646047-3400736F-D380-451C-8513-4EF8770DB86BQ26801642-F2F9D5BC-B24A-4E09-B319-40518820DB67Q26825935-3FFDD66A-E12F-45CA-813D-1F2466D6DF18Q27011373-FCA19C34-C8DB-4395-9127-13612BAB6CB2Q27021242-E1899A18-8E54-4A28-85C7-5A9FF379B9A0Q27022525-9BBC63DB-85B5-477E-B7D6-0D9FD8B124AAQ27026126-F8686020-AF42-48C5-9BD8-89432FEE263DQ28081863-077383D6-F305-4A91-943F-10ED42EED54CQ28397407-08CA27EE-61FB-40D3-9BC3-7C197C68D07DQ28511097-2E859EA1-EE50-494A-BD4B-F30F2F2C3B0AQ28649846-E0A5DB81-AFF8-49C0-9A61-7100FA8B57D6Q30423456-F9481BED-7609-430D-ADC1-F0E7C11B182DQ33720322-21D68B7A-CCC5-4A68-9114-4577A2C2B863Q33745559-19469CEA-FD53-4984-A5FF-EF170B89B129Q33800561-7A02C0BA-6816-4EEB-AC27-2061DD22A053Q34277082-E9F8C9B4-E520-4D24-8F51-453B917FB421Q34297184-67D2A947-DAD1-4D07-8E65-1531B59051F1Q34314664-9EE5D61D-169C-4428-AA01-06284E7B4A68Q34323566-BF9A0FAF-B16F-48EE-A218-56DFBC73E6F2Q34562723-B7A9B87D-0976-48F4-9E3B-42DD4C9517D8Q34700101-1E87EE57-E6BF-42C5-8FDB-F135FEB71BCFQ34767098-957A840F-1BD8-4258-86AB-1DA15110D364Q34991781-77B8F46A-4924-4F6E-9FB4-A7716F3FA1D4Q34991917-C810A3F4-BDC3-4295-85D7-B287510BF4AEQ34994184-AD49CAC7-B5F5-4799-ADE7-50B0B0527994Q35054493-FF305BA6-A3CD-45B4-BB57-09D09AD5BB2DQ35097477-204D5290-4C82-49F3-9AFF-57E3ABD3653CQ35124141-DD03A822-5931-4E79-AFEB-F07B602F0060Q35570422-93261D0F-5680-4B26-8C70-58AE6BEB5377Q35638080-4E36BA24-09CD-4426-BA88-A6BBCA8D3BE3Q35884142-A14ECD23-3DC7-4184-A1BC-E32CB8603B1BQ35928204-FA186740-2DF7-40B0-BCEF-0A0D9A7C60B4Q36227184-32393FB2-4912-437F-BEFB-7ADF325A5B5BQ36291716-D5D50F3E-7BE8-47AF-A953-A5E14C74579FQ36418402-0C4F63A3-D6FE-4CE8-A2C2-232413088429Q36438414-196D32D4-0B70-43C9-97DF-CB1CB1135E51Q36572977-627E0E5E-EF23-4C36-B999-F4F241A6EB1EQ36618671-7124CF83-195A-44E4-BF21-B87DE85D511FQ36633215-C11742F8-89C2-417A-BCA4-E4EF0978FC96
P2860
Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Mannose-binding lectin-deficie ...... ce but no autoimmune phenotype
@ast
Mannose-binding lectin-deficie ...... ce but no autoimmune phenotype
@en
Mannose-binding lectin-deficie ...... ce but no autoimmune phenotype
@nl
type
label
Mannose-binding lectin-deficie ...... ce but no autoimmune phenotype
@ast
Mannose-binding lectin-deficie ...... ce but no autoimmune phenotype
@en
Mannose-binding lectin-deficie ...... ce but no autoimmune phenotype
@nl
prefLabel
Mannose-binding lectin-deficie ...... ce but no autoimmune phenotype
@ast
Mannose-binding lectin-deficie ...... ce but no autoimmune phenotype
@en
Mannose-binding lectin-deficie ...... ce but no autoimmune phenotype
@nl
P2093
P3181
P1476
Mannose-binding lectin-deficie ...... ce but no autoimmune phenotype
@en
P2093
John Savill
Kazue Takahashi
Lynda M Stuart
R Alan B Ezekowitz
P304
P3181
P356
10.4049/JIMMUNOL.174.6.3220
P407
P577
2005-03-15T00:00:00Z